$695 | Single User
$2850 | Multi User
$5650 | Global License

The Healthcare Internet of Things: A Network of Opportunities for All (2016)
[Lowest Price Guaranteed: $695]

Published by FirstWord Pharma: 01 Oct 2016 | 65313 | In Stock
Related Topics: AstraZeneca , Building , Business , Exploration , Healthcare , Internet , Technology

Introduction

Partnering people and technology to build more productive relationships

Clinical and commercial success in pharma has always been dependent on relationships. Now our sector and others are seeing people and technology come together in incredibly exciting new ways, creating stronger connections and enabling continuous and productive conversations to take place in real time. The opportunities for pharma are immense – but finding the right path to follow is challenging.

The Healthcare Internet of Things: A Network of Opportunities for All casts a candid eye over the latest developments and plots a course for pharmaceutical companies wanting to maximise long-term commercial advantage. Based on in-depth discussions with 10 senior industry leaders at the forefront of technology, this report examines how the Internet of Things (IoT) phenomenon can be usefully applied to foster more communicative relationships between pharma, patients, physicians and payers.

Key Features

Clear definition of IoT and an explanation of what it encompasses – including the technologies, tools and approaches that exist today and are already delivering value.

Outline of how the organisational structures within pharma need to evolve to adopt an IoT strategy, including specialist partnerships, leadership culture and data science capabilities.

Expert views on how IoT can be harnessed to power-charge relationships with physicians, patient segments, and payers.

Detailed discussion on what an IoT enabled future could look like plus a clear view on what needs to be in place to get there.

Exploration of how IoT can speed the time-to-market of drugs and drive cost-effective processes.

Key Benefits

Enables more joined-up thinking: Supports a holistic approach - IoT can be applied across multiple areas from trial management to market access, patient-centricity to payer liaison.

Facilitates informed decision-making: Gain the insight needed to formulate targeted IoT strategies that fit with wider business plans, goals and technology capabilities.

Manages business expectations: Draw on case studies with pharma and other industries to identify evidence of benefits being realised and clarity on what is possible.

Provides a clear plan of action: Find out what needs to be in place and the potential pitfalls. Understand the route to setting up and rolling out an IoT strategy.

Why IoT matters for pharma

A highly connected healthcare ecosystem will ultimately help pharma serve patients better. IoT may be in its infancy today, however those that implement gradual, planned and controlled changes now will be best placed to realise the benefits of a connected future.

Earlier diagnosis is widely expected to be one of the most important IoT outcomes. The huge leaps made by IBM’s Watson is a prime example of what is already possible. Ultimately, IoT is a business issue, not just an IT one, as it has the potential to fundamentally change the way clinical and commercial decisions are made across the drug lifecycle.

Key Questions Answered By This Report:

Evolution or revolution? What structures and business models are needed to leverage IoT to meet commercial and/or clinical business objectives?

What evidence already exists to support the strategic, financial and operational benefits gained from putting in place an IoT strategy?

What can pharma learn from other industries with more evolved experience in applying IoT thinking to their stakeholder relationships?

Who should pharma look to partner with and what type of partner companies should be considered? Are single or multiple relationships required?

Expert Views

Duncan Arbour, Innovation Lead at Inventive Health Europe

Matt Bolton, Associate Strategy Director at Clear M&C Saatchi

Christopher Colucci, Head of Enterprise Applications at Insmed

Philipp Diesinger, Global Chief Data Scientist at Boehringer

Laurent Flouret, Director – Global Digital Strategy & Innovation at Sanofi

Daniel George, Digital Experience Leader in Global Commercial Excellence at AstraZeneca

Magnus Jörntén-Karlsson, Project Director, Pharmaceutical Innovations, AstraZeneca R&D

Valerio Nannini, Senior Vice President, Head of Strategies and Performance at Nestlé

Daniel Ramirez, International Head of Business Development, LEO Innovation Lab, LEO Pharma A/S

Jane Rhodes, Senior Director of New Initiatives for the Value-Based Medicine team at Biogen

“Now, you can have more digital eyes and ears on the pre-clinical, clinical and real world data, and far greater ability to make sense of this. It’s the potential for no meaningful change in data, no matter how tiny, to be missed.”

Duncan Arbour, Inventive Health Europe

“The nature of the IoT in healthcare is that it brings the patient to the fore in their treatment journey, and as such, if pharma can develop its position here, it can develop closer relationships with patients.”

Matt Bolton of Clear M&C Saatchi

“IoT has the potential to disrupt traditional methods of clinical development processes, improve decision making and speed up drug development.”Jane Rhodes of Biogen

Who will benefit from this report?

Senior-leadership teams and key decision-makers

Commercial and clinical department leads

Relationship management and customer care specialists

Technology departments and IT investment decision-makers

Human resources and talent finders

Payer liaison

Trial designers and managers

Content Highlights

Growing connectivity as momentum for the Internet-of-Things (IoT)

Embracing the IoT in healthcare and pharma

Key insights

Key drivers of the IoT

Patient-centricity and the IoT

The potential of the IoT for other stakeholders

Physicians and HCPs

Pharmacies

Payers

The current status of the healthcare IoT

The Tools of the IoT

Key insights

Wearables

Analytics

Cloud computing

Cognitive systems

Blockchain

The IoT as a strategic consideration for pharma and healthcare

Key insights

Patient monitoring and improved diagnosis, adherence and outcomes

R&D and real-world data

Value-adding services

Customer satisfaction and customer experience management

Faster time-to-market and commercial effectiveness

Challenges and Resistors to uptake of the IoT

Key insights

Are the regulations around IoT solution development clearly defined?

Will IoT be data secured?

Is technology mature enough?

What does a successful IoT pilot programme look like?

Will there be an ROI from the IoT?

Accentuating positive opportunities from the IoT

Key insights

Learning from other industries

Collaborating with the best for effective business models

Optimising touchpoints for customer engagement

Allow the IoT to shake up clinical trials and R&D

Building a truly integrated, trusted network of care

Organisational structure and the IoT

Key insights

Think data, think connectivity

Data science capabilities

Tech-savvy leadership to facilitate IoT success

The Future of IoT in healthcare

Key insights

Unparalleled healthcare access and communication

Regulatory agencies need to be supportive

Change in business model

Conclusions

Expert biographies

About FirstWord

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.

FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.

FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.

Table of Contents
for The Healthcare Internet of Things: A Network of Opportunities for All (2016)

  • 1. Executive summary

    2. Research objectives

    3. Research methodology

    3.1 Experts interviewed

    4. Definitions

    5. Growing connectivity as momentum for the Internet-of-Things

    6. Embracing the IoT in healthcare and pharma

    6.1 Key insights

    6.2 Key drivers of the IoT

    6.3 Patient-centricity and the IoT

    6.4 The potential of the IoT for other stakeholders

    6.4.1 Physicians and HCPs

    6.4.2 Pharmacies

    6.4.3 Payers

    6.5 The current status of the healthcare IoT

    7. The Tools of the IoT

    7.1 Key insights

    7.2 Wearables

    7.3 Analytics

    7.4 Cloud computing

    7.5 Cognitive systems

    7.6 Blockchain

    8. The IoT as a strategic consideration for pharma and healthcare

    8.1 Key insights

    8.2 Patient monitoring and improved diagnosis, adherence and outcomes

    8.3 R&D and real-world data

    8.4 Value-adding services Customer satisfaction and customer experience management

    8.5 Faster time-to-market and commercial effectiveness

    9. Challenges and Resistors to uptake of the IoT

    9.1 Key insights

    9.2 Are the regulations around IoT solution development clearly defined?

    9.3 Will IoT be data secured?

    9.4 Is technology mature enough?

    9.5 What does a successful IoT pilot programme look like?

    9.6 Will there be an ROI from the IoT?

    10. Accentuating positive opportunities from the IoT

    10.1 Key insights

    10.2 Learning from other industries

    10.3 Collaborating with the best for effective business models

    10.4 Optimising touchpoints for customer engagement

    10.5 Allow the IoT to shake up clinical trials and R&D

    10.6 Building a truly integrated, trusted network of care

    11. Organisational structure and the IoT

    11.1 Key insights

    11.2 Think data, think connectivity

    11.3 Data science capabilities

    11.4 Tech-savvy leadership to facilitate IoT success

    12. The Future of IoT in healthcare

    12.1 Key insights

    12.2 Unparalleled healthcare access and communication

    12.3 Regulatory agencies need to be supportive

    12.4 Change in business model Conclusion

    13. Appendix

    13.1 Expert biographies

Additional Details

Publisher

FirstWord Pharma

Publisher Information

Reference

65313 |

Report Format

PDF

FirstWord Pharma Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Monica Healthcare Limited - Medical Equipment - Deals and Alliances Profile
SummaryMonica Healthcare Ltd (MHL) is a medical device company that develops and commercializes labo...
23 Oct 2015 by Global Data USD $250 More Info
Perfint Healthcare Pvt. Ltd. - Medical Equipment - Deals and Alliances Profile
SummaryPerfint Healthcare Pvt. Ltd. (Perfint) is a medical solutions provider. It develops solutions...
23 Oct 2015 by Global Data USD $250 More Info
Allied Healthcare Products, Inc. (AHPI) - Financial and Strategic SWOT Analysis Review
Allied Healthcare Products, Inc. (AHPI) - Financial and Strategic SWOT Analysis Review provides you ...
20 Oct 2015 by Global Data USD $125 More Info
Digital Healthcare Ltd - Medical Equipment - Deals and Alliances Profile
SummaryDigital Healthcare Ltd (DHC), a subsidiary of Egton Medical Information Systems Limited is a ...
16 Oct 2015 by Global Data USD $250 More Info
API Healthcare Corporation - Medical Equipment - Deals and Alliances Profile
SummaryAPI Healthcare Corporation (API Healthcare) is a healthcare organization that provides workfo...
15 Oct 2015 by Global Data USD $250 More Info
AdvantEdge Healthcare Solutions, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAdvantEdge Healthcare Solutions, Inc. (AHS) is a medical billing and practice management comp...
15 Oct 2015 by Global Data USD $250 More Info
Agfa HealthCare NV - Medical Equipment - Deals and Alliances Profile
SummaryAgfa HealthCare NV (Agfa HealthCare) a subsidiary of Agfa-Gevaert NV is a healthcare technolo...
15 Oct 2015 by Global Data USD $250 More Info
The Rise of Wearable Healthcare Technology: Opportunities and Challenges for Pharma
IntroductionIn The Rise of Wearable Healthcare Technology: Opportunities and Challenges for Pharma, ...
01 Feb 2015 by FirstWord Pharma USD $695 More Info
Physician Views: Can the launch of ViiV Healthcare's dolutegravir disrupt Gilead's dominance in the HIV market?
ScopeBased on current timelines, the FDA is poised to approve the HIV therapy dolutegravir later thi...
01 Aug 2013 by FirstWord Pharma USD $695 More Info
Inside China’s Healthcare Reforms: Opportunities for Multinational Pharma
IntroductionIn 2009, China’s government announced plans to invest RMB1.13 trillion (0 billion) in...
01 Jun 2012 by FirstWord Pharma USD $995 More Info

This report is published by FirstWord Pharma

Download Free Report Summary PDF

The Healthcare Internet of Things: A Network of Opportunities for All (2016) | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...